Thermo Fisher Scientific Change in Tax Valuation Allowance increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$28.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
A decrease in the allowance suggests improved confidence in future profitability and tax asset utilization.
Measures the net change in the valuation allowance established against deferred tax assets. A valuation allowance is rec...
Standard disclosure for companies with significant deferred tax assets and fluctuating earnings outlooks.
tmo_tax_valuation_allowance_change| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.00M | -$11.00M | -$87.00M | -$88.00M | $415.00M | $67.00M | -$1.00M | -$183.00M | $47.00M | -$183.00M | -$25.00M | -$28.00M | $0.00 |
| QoQ Change | — | -136.7% | -690.9% | -1.1% | +571.6% | -83.9% | -101.5% | <-999% | +125.7% | -489.4% | +86.3% | -12.0% | +100.0% |
| YoY Change | — | — | — | -393.3% | >999% | +177.0% | +98.9% | -144.1% | -29.9% | <-999% | +86.3% | -159.6% | +100.0% |